MACK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Stats
今日成交量	187 112
平均成交量	141 696
市值	217.98M
EPS	$0 ( 2024-05-02 )
下一个收益日期	( $0 ) 2024-05-06
Last Dividend	$0.500 ( 2019-12-13 )
Next Dividend	$0 ( N/A )
P/E	-187.50
ATR14	$0.00500 (0.03%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Andersen Eric	Buy	857	Common Stock
2023-12-26	Andersen Eric	Buy	48 693	Common Stock
2023-12-07	Andersen Eric	Buy	76 384	Common Stock
2023-12-07	Andersen Eric	Buy	24 666	Common Stock
2023-11-17	Andersen Eric	Buy	235	Common Stock

INSIDER POWER
99.81
Last 100 transactions
Buy: 1 159 920 \| Sell: 7 000

音量相关性

長: 0.09 (neutral)

短: 0.11 (neutral)

Signal:(43.996) Neutral

Merrimack Pharmaceuticals 相关性

10 最正相关
TA	0.984
IIN	0.983
ATCX	0.983
ECHO	0.98
MOR	0.973
EZPW	0.957
META	0.947
PNT	0.947
KRTX	0.946
TESS	0.945

10 最负相关
SJ	-0.966
BIOL	-0.964
CHTR	-0.961
MRBK	-0.96
UTMD	-0.955
WTER	-0.951
CYXT	-0.948
GNPX	-0.946
LBRDK	-0.945
LBRDA	-0.945

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Merrimack Pharmaceuticals 相关性 - 货币/商品

-0.38
( neutral )

-0.44
( neutral )

0.00
( neutral )

0.50
( neutral )

0.28
( neutral )

Merrimack Pharmaceuticals 财务报表

Annual	2023
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-0.0826

FY	2023
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-0.0826

FY	2022
营收:	$0
毛利润:	$-445 000 (0.00 %)
EPS:	$-0.110

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.180

Financial Reports:

No articles found.

Merrimack Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Merrimack Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$8.30	2017-05-30
Last Dividend	$0.500	2019-12-13
Next Dividend	$0	N/A
Payout Date	2019-12-23
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	$10.30	--
Avg. Dividend % Per Year	0.00%	--
Score	0.23	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2025-09-03)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.23

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	$8.30	26.40%
2018	$0	0.00%
2019	$1.997	62.60%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.0524	1.200	-1.746	-2.10	[0 - 0.3]
returnOnEquityTTM	-0.0531	1.500	-1.701	-2.55	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	43.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	42.80	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	13.58	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.0708	[0 - 30]
freeCashFlowPerShareTTM	-0.106	2.00	-0.0531	-0.106	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				0.695

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-214.01	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0531	2.50	-1.093	-2.55	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.106	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.0708	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.22	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-0.537

Merrimack Pharmaceuticals